Full text is available at the source.
Abstract
In 2024, France began its first clinical trials investigating the therapeutic potential of psychedelics in psychiatry.
- Psychedelic substances like LSD, psilocybin, and dimethyltryptamine are being reconsidered for therapeutic use.
- International clinical research on psychedelics has been ongoing since the 2010s.
- The study focused on the knowledge and attitudes of French mental health professionals towards psychedelics.
- Perceptions of psychedelics vary between clinical and recreational contexts among professionals.
Simplified